Mipomersen, an apolipoprotein B synthesis inhibitor : A literature study analyzing efficacy and safety when used for treating patients with familial hypercholesterolemia
Familial hypercholesterolemia is a genetic disease affecting about 10 million people around the world. Those who carry the disease have a very high risk of developing cardiovascular diseases and commonly encounter myocardial infarction at the early age of 40. Therefore, a diagnosis and immediate tre...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Linnéuniversitetet, Institutionen för kemi och biomedicin (KOB)
2019
|
| Subjects: | |
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-82374 |